Treatment of pulmonary haemorrhage and oedema

摘要

Method for inhibiting pulmonary haemorrhage and oedema associated with an intracranial syndrome comprises administering vinpocetine (I). Dosage is 10-200 (pref. 50-150) mg/kg. (I) is known (see US4035370) for its cerebral vasodilatory activity. Other suitable ester forms of apovincaminic acid, as described in US4035372 may also be used.